NICOX (EPA:COX) | WebDisclosure

Basculer en Français

10948	Companies
239368	Keywords
168210	Articles
128743	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 12/16/2025 at 07:30, 8 months 23 days ago

Nicox finalise la génération des données clés de demande d’autorisation de mise sur le marché de NCX 470 pour un dépôt maintenu au premier semestre 2026
Nicox finalise la génération des données clés pour la demande d’autorisation de mise sur le marché de NCX 470, dépôt maintenu au premier semestre 2026. Réunions pré-NDA avec la FDA américaine et dépôt NDA en Chine également en bonne voie

FDA Autorisation De Mise Sur Le Marché Nicox NCX 470 Dépôt NDA
PRESS RELEASE

published on 12/16/2025 at 07:30, 8 months 23 days ago

Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026
Nicox completes key data generation for NCX 470 new drug application submission in H1 2026, including clinical trial and stability data. U.S. and China submissions on track

FDA Clinical Trials Nicox NCX 470 New Drug Application
BRIEF

published on 10/23/2025 at 07:35, 10 months 16 days ago

Nicox publie ses résultats financiers du premier semestre 2025

Résultats Financiers Ophtalmologie Remboursement De La Dette Contrôle Des Coûts NCX 470
BRIEF

published on 10/23/2025 at 07:35, 10 months 16 days ago

Nicox Releases First Half 2025 Financial Results

Financial Results Debt Repayment Ophthalmology Cost Control NCX 470
PRESS RELEASE

published on 10/23/2025 at 07:30, 10 months 16 days ago

Nicox Provides First Half 2025 Financial Results
Nicox provides first half 2025 financial results, expects NDA submissions for NCX 470 in 2026. Company aims to finance operations for 12 months and repay debts by 2026

Financial Results Debt Repayment Nicox NCX 470 NDA Submissions
BRIEF

published on 10/02/2025 at 07:35, 11 months 6 days ago

Nicox : Résultats positifs pour NCX 470 dans l'étude Denali

Essai Clinique Ophtalmologie Nicox NCX 470 Pression Intraoculaire
BRIEF

published on 10/02/2025 at 07:35, 11 months 6 days ago

Nicox: Positive results for NCX 470 in the Denali study

Clinical Trial Ophthalmology Nicox NCX 470 Intraocular Pressure
PRESS RELEASE

published on 10/02/2025 at 07:30, 11 months 6 days ago

Nicox annonce que NCX 470 a démontré une efficacité soutenue jusqu’à 12 mois dans l’essai clinique Denali, sans effets indésirables nouveaux observés
Nicox annonce que NCX 470 a démontré une efficacité soutenue jusqu’à 12 mois dans l’essai clinique Denali, sans effets indésirables nouveaux observés. Les analyses préplanifiées confirment un profil similaire à Mont Blanc

Étude Clinique Ophtalmologie Nicox NCX 470 Denali
PRESS RELEASE

published on 10/02/2025 at 07:30, 11 months 6 days ago

Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations
Nicox's NCX 470 shows sustained efficacy with no new safety concerns in Denali trial. Data presented at upcoming ophthalmology conferences

Nicox NCX 470 Denali Trial Ophthalmology Conferences Sustained Efficacy
BRIEF

published on 09/04/2025 at 07:35, 1 year ago

Nicox Plans Debt Repayment with NCX 470 Progress

Debt Repayment Ophthalmology Licensing Nicox NCX 470

Accesswire

Published on 09/09/2026 at 00:35, 4 hours 7 minutes ago

Troubadour Resources Announces Non-Brokered Unit Private Placement and Convertible Debenture Financing
Published on 09/09/2026 at 00:25, 4 hours 17 minutes ago

Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Published on 09/08/2026 at 23:35, 5 hours 7 minutes ago

The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
Published on 09/08/2026 at 22:30, 6 hours 12 minutes ago

Grid Metals Announces Positive Mineralogical Results at Falcon West, Engages SGS Canada for Ore Sorting Test Work, and Announces Investor Relations Agreements
Published on 09/08/2026 at 22:15, 6 hours 27 minutes ago

GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement

View all ACCESSWIRE

EQS Group

Published on 09/08/2026 at 22:50, 5 hours 51 minutes ago

Cataneo Set to Unveil the Future of AI Engagement at IBC2026 in Amsterdam
Published on 09/08/2026 at 22:05, 6 hours 36 minutes ago

oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 10 hours 12 minutes ago

Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 18:30, 10 hours 12 minutes ago

Designated Person Notification
Published on 09/08/2026 at 18:30, 10 hours 12 minutes ago

Designated Person Notification

Les Echos

Published on 09/08/2026 at 17:45, 10 hours 57 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 10 hours 57 minutes ago

Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 17:45, 10 hours 57 minutes ago

Damartex / Résultats de l'exercice 2025-2026
Published on 09/08/2026 at 11:00, 17 hours 42 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 17 hours 42 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL

View all LES ECHOS COMFI WIRE